|
HARBI1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.722100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.004600E-03 |
| Normal-vs-Stage2 |
9.464200E-01 |
| Normal-vs-Stage3 |
2.456100E-03 |
| Normal-vs-Stage4 |
2.69220000004289E-06 |
| Stage1-vs-Stage2 |
1.876090E-02 |
| Stage1-vs-Stage3 |
3.173000E-01 |
| Stage1-vs-Stage4 |
9.975800E-04 |
| Stage2-vs-Stage3 |
6.716500E-03 |
| Stage2-vs-Stage4 |
4.34120000000204E-05 |
| Stage3-vs-Stage4 |
1.897680E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.956400E-03 |
| Normal-vs-AfricanAmerican |
1.953620E-02 |
| Normal-vs-Asian |
3.801800E-03 |
| Caucasian-vs-AfricanAmerican |
5.376800E-01 |
| Caucasian-vs-Asian |
3.643000E-01 |
| AfricanAmerican-vs-Asian |
9.545000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.702400E-03 |
| Normal-vs-Female |
7.620700E-03 |
| Male-vs-Female |
1.799640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.139930E-02 |
| Normal-vs-Age(41-60Yrs) |
2.155100E-03 |
| Normal-vs-Age(61-80Yrs) |
5.226200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.142200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.625200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.378200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.651200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.432800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.033400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.501600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.502800E-01 |
| Classical-VS-Follicular |
1.117170E-01 |
| Classical-VS-Other |
1.625440E-01 |
| Classical-VS-Normal |
2.283600E-03 |
| Tall-VS-Follicular |
7.111900E-02 |
| Tall-VS-Other |
3.126000E-01 |
| Tall-VS-Normal |
6.343800E-03 |
| Follicular-VS-Other |
9.970400E-02 |
| Follicular-VS-Normal |
2.194800E-01 |
| Other-VS-Normal |
1.557640E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.145800E-02 |
| Normal-vs-N1 |
1.224380E-04 |
| N0-vs-N1 |
2.895400E-03 |
|
|
